Published: 2014-07-14 14:08:37
SUMMARY
Frederic Zenhausern, Ph.D., MBA, President, WhiteSpace Enterprise Corporation (“WSE”) is developing platform technologies and commercial products combining methods from physical sciences and integrated microsystems for automating and miniaturizing the workflow processing of biological specimens. These platforms have broad applications for point-of-care testing that will enable precise and mobile health analysis ranging from rapid DNA analysis to predictive biomarkers for molecular diagnostics. The company’s design of genomic and proteomic biomarkers panel for monitoring radiation sensitivities will provide new ways for guiding personalized treatment in radiotherapies that that will improve value in healthcare delivery.
